We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App




Two Simple Methods Prepare DNA Suitable For Digital PCR

By LabMedica International staff writers
Posted on 19 Aug 2020
Although DNA of high quality can be easily prepared from cultured cells with commercially available kits, many studies involve a large number of samples which increases the cost drastically.

In addition, a limited amount of each sample is often a challenge, for example, for studies using cells of primary cultures for testing multiple drugs at multiple concentrations in multiple replicates, and studies or diagnosis involving defined subpopulations of human immune cells.

Medical scientists at the University Hospital Hamburg‐Eppendorf (Hamburg, Germany) used cells from a primary culture derived from a benign plexiform neurofibroma, a melanoma cell line, and a human fibroblast line. More...
The cells were seeded into wells of 96‐well plates with at different concentrations, each in three replicates. The plates were incubated overnight for the cells to attach the cultural surface and subjected to DNA extraction on the next day after checking the adhesive living cells under a microscope.
After removing the medium, the wells were washed twice with PBS. Subsequently, 70 μL of the Direct PCR lysis reagent (PeqLab, Erlangen, Germany) supplemented with 0.2 mg/mL fresh proteinase K together with 70μL water was added to each well containing adhesive living cells. Supernatants containing the extracted DNA were further purified by precipitation. The team also lysed cells using chelex100 powder (Bio-Rad, Hercules, CA, USA). Conventional polymerase chain reaction (PCR) was carried out using 2 µL out of the 10 µL DNA and a primer pair for an exon of the NF1 gene which is used for the routine genetic diagnosis in their laboratory.

The investigators reported that for 1,000 cells from one primary culture and two tumor cell lines, DNA was reproducible and obtained with recovery rate (obtained/expected amount of DNA) in the range of 50%‐90% as measured by the fluorometer dyes instrument Qubit (Thermo Fisher Scientific, Waltham, MA, USA). For digital PCR, more than 1,600 positive droplets were obtained for DNA from 1,000 cells using the Direct PCR method, corresponding to a yield efficiency of approximately 80%. Further reducing the number of cells down to 100 would be possible with 160 positive droplets expected. Both reagents are inexpensive at EUR 0.08/sample.

The authors concluded that the two methods were efficient; especially the Direct PCR reagent‐based method provides a simple and inexpensive method for preparing DNA suitable for digital PCR from small number of cells. The study was published on August 5, 2020 in the Journal of Clinical Laboratory Analysis.

Related Links:

University Hospital Hamburg‐Eppendorf
PeqLab
Bio-Rad
Thermo Fisher Scientific

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
POC Immunoassay Analyzer
Procise DX
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Molecular Diagnostics

view channel
Image: The proposed workflow adds liquid biopsy to detect genetic and molecular signs of cancer in CSF samples already collected during autoimmune encephalitis evaluation. (Image Credit: Shutterstock)

CSF Liquid Biopsy Could Help Distinguish Cancer from Autoimmune Brain Inflammation

Autoimmune encephalitis can cause memory and behavioral changes, seizures, and altered consciousness, but diagnosis can be challenging because cancers involving the brain and central nervous system may... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Ebola remains a rapidly evolving public health threat with high mortality, underscoring the need for timely diagnosis and decentralized testing closer to patients (Image Credit: Adobe Stock)

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) and ReadyGo Diagnostics Ltd. (Bath, UK) have initiated a collaboration to evaluate ReadyGo’s GoCollect with the Co-Dx PCR platform for blood-based molecular... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.